|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
11.760 -0.220 (-1.836%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.17
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 29.00 RMB (cts) | |
| Net Profit | 733.17 RMB (MIL) | DPS | 16.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,216.00 | 48.55 | 20.28 | -- | 1,323.40 | 893.06 |
| 2026 | 1,443.50 | 58.40 | 22.69 | -- | 2,818.68 | 1,016.00 |
| 2027 | 1,818.41 | 68.00 | 27.59 | -- | 1,927.00 | 1,200.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 893.06 | 36.00 | 20.56 | HUATAI FIN HLDGS HK | Buy | 14.65 | 27/06/2025 | |
| 2025 | 1,237.00 | 50.00 | 24.36 | UBS | Buy | 14.50 | 10/07/2025 | |
| 2025 | 1,253.00 | 50.00 | -- | BOCOM | Buy | 14.30 | 04/06/2025 | |
| 2025 | 1,182.00 | 48.00 | 20.00 | CICC | OutPerform | 12.80 | 24/06/2025 | |
| 2025 | 1,323.40 | 49.00 | -- | MORGAN STANLEY | Equal-weight | 12.30 | 20/07/2025 | |
| 2025 | 1,195.00 | 48.10 | 14.40 | BOCI | Buy | 8.90 | 26/03/2025 | |
| 2026 | 1,016.00 | 41.00 | 23.37 | HUATAI FIN HLDGS HK | -- | -- | 27/06/2025 | |
| 2026 | 1,549.00 | 63.00 | 31.18 | UBS | -- | -- | 10/07/2025 | |
| 2026 | 1,580.00 | 63.60 | -- | BOCOM | -- | -- | 04/06/2025 | |
| 2026 | 1,301.00 | 53.00 | 22.00 | CICC | -- | -- | 24/06/2025 | |
| 2026 | 2,818.68 | 105.00 | -- | MORGAN STANLEY | -- | -- | 20/07/2025 | |
| 2026 | 1,338.00 | 53.80 | 16.10 | BOCI | -- | -- | 26/03/2025 | |
| 2027 | 1,200.00 | 49.00 | 27.59 | HUATAI FIN HLDGS HK | -- | -- | 27/06/2025 | |
| 2027 | 1,832.00 | 74.00 | 37.03 | UBS | -- | -- | 10/07/2025 | |
| 2027 | 1,927.00 | 77.50 | -- | BOCOM | -- | -- | 04/06/2025 | |
| 2027 | 1,818.41 | 68.00 | -- | MORGAN STANLEY | -- | -- | 20/07/2025 | |
| 2027 | 1,666.00 | 67.00 | 20.10 | BOCI | -- | -- | 26/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 23/07/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |